Saturn Selects AIXTRON MOCVD Reactor for Solar Cell Production

Russia-based company, Saturn has placed a new order for AIXTRON’s MOCVD reactor system for solar cell production. The order includes an AIX 2800 G4-R 15x4’’ configuration deposition system with an automated wafer transfer platform.

The delivery of the AIXTRON MOCVD reactor is scheduled to be in the Q2 of 2011. The reactor will be utilized for manufacturing Gallium Arsenide (GaAs) solar cell epitaxial materials for the space market in Russia. In addition, the AIXTRON Europe support team will commission the MOCVD system in a dedicated plant together with the currently used AIXTRON reactor at Saturn’s Krasnodar manufacturing plant.

Saturn’s Director General, Anatoly Skursky stated that the company is pleased with the ease of operation and performance offered by the AIXTRON system. Skursky added that AIXTRON helped the company in achieving the complete production status in a short period of time.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AIXTRON SE. (2019, February 28). Saturn Selects AIXTRON MOCVD Reactor for Solar Cell Production. AZoOptics. Retrieved on July 14, 2024 from https://www.azooptics.com/News.aspx?newsID=12944.

  • MLA

    AIXTRON SE. "Saturn Selects AIXTRON MOCVD Reactor for Solar Cell Production". AZoOptics. 14 July 2024. <https://www.azooptics.com/News.aspx?newsID=12944>.

  • Chicago

    AIXTRON SE. "Saturn Selects AIXTRON MOCVD Reactor for Solar Cell Production". AZoOptics. https://www.azooptics.com/News.aspx?newsID=12944. (accessed July 14, 2024).

  • Harvard

    AIXTRON SE. 2019. Saturn Selects AIXTRON MOCVD Reactor for Solar Cell Production. AZoOptics, viewed 14 July 2024, https://www.azooptics.com/News.aspx?newsID=12944.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.